Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI. Chronic hand eczema (CHE) ...

Hand eczema, or hand dermatitis, is an inflammatory skin condition. Swollen, itchy, scaly, discolored rashes form on the fingers and hands. The skin may blister and crack, and it can be painful. Hand ...

Please provide your email address to receive an email when new articles are posted on . In two phase 3 trials, delgocitinib cream improved hand eczema in a greater proportion of patients vs. vehicle.

Epidemiology, clinical presentation. Hyperkeratotic hand dermatitis is more common in men and mainly occurs between the ages of 40 to 60 years old (MennE9, 2000; Warshaw et al., 2003). The skin does ...

A deeper understanding of chronic hand eczema (CHE) -- its pathogenesis, clinical subtypes and presentation, and risk factors -- would help expedite quicker diagnosis and appropriate care. That's the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Lebrikizumab treatment improved both face and hand ...

San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago from two separate trials in patients with ...

The trial met its primary endpoint with a significantly larger proportion of delgocitnib-treated patients achieving treatment success. Delgocitinib cream significantly improved chronic hand eczema in ...

Every time Rebecca publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Treatment options for severe chronic hand eczema are limited and carry troublesome adverse effects. Delgocitinib cream had superior efficacy compared with oral alitretinoin for this patient population ...

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, will present new data and insights in moderate-to-severe atopic dermatitis and chronic hand eczema at the ...